Acetylsalicylic Acid
Embolism
St. Antonius HospitalPhase 4 / ApprovedActive
BBB
73/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 58/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Embolism cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Edoxaban St. Antonius Hospital | Phase 4 | BBB |
WARFARIN Daiichi Sankyo | Phase 3 | BB |
Rivaroxaban Bayer | Phase 3 | BB |
Plavix Assistance Publique - Hôpitaux de Paris | Phase 3 | BB |
BAY 59-7939 Bayer | D |
Same molecule, other indications
Acetylsalicylic Acid is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →